Arvest Investments’s Eli Lilly LLY Stock Holding History

Arvest Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	918 -3	-0.3%	-$3.06K	0.13%	98
2026 Q1	$847K	Sell	921 -46	-5%	-$46.6K	0.12%	111
2025 Q4	$1.04M	Sell	967 -2,702	-74%	-$2.58M	0.15%	103
2025 Q3	$2.8M	Buy	3,669 +2,384	+186%	+$1.77M	0.4%	50
2025 Q2	$1M	Buy	1,285 +200	+18%	+$155K	0.15%	113
2025 Q1	$896K	Buy	1,085 +180	+20%	+$150K	0.14%	122
2024 Q4	$699K	Buy	905 +35	+4%	+$29K	0.11%	124
2024 Q3	$771K	Buy	870 +42	+5%	+$37.8K	0.12%	120
2024 Q2	$750K	Buy	828 +36	+5%	+$28.8K	0.12%	116
2024 Q1	$616K	Buy	+792	New	+$564K	0.1%	116

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Arvest Investments's LLY Position: Q2 2026 in Review

Arvest Investments reduced its Eli Lilly (LLY) stake by 0.33% in Q2 2026, selling an estimated $3.06K and leaving 918 shares worth $1.1M. The position accounts for 0.13% of the portfolio, ranked #98.

Arvest Investments first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.8M in Q3 2025. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Arvest Investments held 918 shares of Eli Lilly worth $1.1M as of Q2 2026.
Arvest Investments sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
Eli Lilly made up 0.13% of Arvest Investments's portfolio in Q2 2026, its #98 holding.
Arvest Investments first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
Arvest Investments's Eli Lilly position peaked at $2.8M in Q3 2025.
1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arvest Investments's 13F filing for Q2 2026, filed 17 Jul 2026.